Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
Financials
Financial year 2025
RheADC from Leuven, company number BE1014500036, closed financial year 2025 with a result of € -124,379 after tax. For that financial year RheADC recorded a gross margin of € -116,226 and equity of € -114,379. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ -114,379
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -124,379
Profit after tax over the fiscal year.
€ 11,388
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -124,379.
Debts at end 2025
€ 100,000
Loans from banks and other lenders, long and short.
€ 37,982
Supplier invoices still open on the last day of the fiscal year.
Ask about RheADC the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to RheADC?
What happened at RheADC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 124,379. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Leuven. KBO
- Katrien Reynders-Frederix became a director. NBB
- Erwin Blomsma became a director. NBB
Management
Behind RheADC are Katrien Reynders-Frederix and Erwin Blomsma. Erwin Blomsma is also behind ESBEE, ViroVet and Benno Therapeutics.
Directors
According to the 2025 annual accounts
Katrien Reynders-Frederix
Director
since 2024
since 2024
Establishments
Establishment units
Physical locations of this company
Ambachtenlaan 1
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Leuven
Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 21 active companies in Leuven, largest first.
€ 3.2 million gross margin · 2025
€ 2.6 million gross margin · 2025
€ 413,084 gross margin · 2025
€ 320,026 gross margin · 2025
€ 78,591 gross margin · 2025
€ 63,990 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Erwin Blomsma(oprichter) 50%
- Katrien Reynders-Frederix(oprichter) 50%
Details
- Company number
- 1014.500.036
- VAT number
- BE 1014.500.036
- Registered office
- Ambachtenlaan 1, 3001 Leuven
- Names & denominations
- RheADC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 October 2024
- Peppol
- Active · Active since 15 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van farmaceutische grondstoffen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten